Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases

Abstract Neural stem cells (NSCs) have increasingly been recognized as the most promising candidates for cell-based therapies for the central nervous system (CNS) injuries, primarily due to their pluripotent differentiation capabilities, as well as their remarkable secretory and homing properties. I...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiangwen Tang, Peng Deng, Lin Li, Yuqing He, Jinchao Wang, Dingjun Hao, Hao Yang
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-024-04089-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850100205978910720
author Xiangwen Tang
Peng Deng
Lin Li
Yuqing He
Jinchao Wang
Dingjun Hao
Hao Yang
author_facet Xiangwen Tang
Peng Deng
Lin Li
Yuqing He
Jinchao Wang
Dingjun Hao
Hao Yang
author_sort Xiangwen Tang
collection DOAJ
description Abstract Neural stem cells (NSCs) have increasingly been recognized as the most promising candidates for cell-based therapies for the central nervous system (CNS) injuries, primarily due to their pluripotent differentiation capabilities, as well as their remarkable secretory and homing properties. In recent years, extensive research efforts have been initiated to explore the therapeutic potential of NSC transplantation for CNS injuries, yielding significant advancements. Nevertheless, owing to the formation of adverse microenvironment at post-injury leading to suboptimal survival, differentiation, and integration within the host neural network of transplanted NSCs, NSC-based transplantation therapies often fall short of achieving optimal therapeutic outcomes. To address this challenge, genetic modification has been developed an attractive strategy to improve the outcomes of NSC therapies. This is mainly attributed to its potential to not only enhance the differentiation capacity of NSCs but also to boost a range of biological activities, such as the secretion of bioactive factors, anti-inflammatory effects, anti-apoptotic properties, immunomodulation, antioxidative functions, and angiogenesis. Furthermore, genetic modification empowers NSCs to play a more robust neuroprotective role in the context of nerve injury. In this review, we will provide an overview of recent advances in the roles and mechanisms of NSCs genetically modified with various therapeutic genes in the treatment of neural injuries and neural disorders. Also, an update on current technical parameters suitable for NSC transplantation and functional recovery in clinical studies are summarized.
format Article
id doaj-art-4d0c90fb7ee24b0689eee37a651f02ae
institution DOAJ
issn 1757-6512
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj-art-4d0c90fb7ee24b0689eee37a651f02ae2025-08-20T02:40:21ZengBMCStem Cell Research & Therapy1757-65122024-12-0115112710.1186/s13287-024-04089-1Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseasesXiangwen Tang0Peng Deng1Lin Li2Yuqing He3Jinchao Wang4Dingjun Hao5Hao Yang6Translational Medicine Center, Hong Hui Hospital, Xi’an Jiaotong UniversityTranslational Medicine Center, Hong Hui Hospital, Xi’an Jiaotong UniversityBasic Medical School Academy, Shaanxi University of Chinese MedicineBasic Medical School Academy, Shaanxi University of Chinese MedicineTranslational Medicine Center, Hong Hui Hospital, Xi’an Jiaotong UniversityDepartment of Spine Surgery, Hong Hui Hospital, Xi’an Jiaotong UniversityTranslational Medicine Center, Hong Hui Hospital, Xi’an Jiaotong UniversityAbstract Neural stem cells (NSCs) have increasingly been recognized as the most promising candidates for cell-based therapies for the central nervous system (CNS) injuries, primarily due to their pluripotent differentiation capabilities, as well as their remarkable secretory and homing properties. In recent years, extensive research efforts have been initiated to explore the therapeutic potential of NSC transplantation for CNS injuries, yielding significant advancements. Nevertheless, owing to the formation of adverse microenvironment at post-injury leading to suboptimal survival, differentiation, and integration within the host neural network of transplanted NSCs, NSC-based transplantation therapies often fall short of achieving optimal therapeutic outcomes. To address this challenge, genetic modification has been developed an attractive strategy to improve the outcomes of NSC therapies. This is mainly attributed to its potential to not only enhance the differentiation capacity of NSCs but also to boost a range of biological activities, such as the secretion of bioactive factors, anti-inflammatory effects, anti-apoptotic properties, immunomodulation, antioxidative functions, and angiogenesis. Furthermore, genetic modification empowers NSCs to play a more robust neuroprotective role in the context of nerve injury. In this review, we will provide an overview of recent advances in the roles and mechanisms of NSCs genetically modified with various therapeutic genes in the treatment of neural injuries and neural disorders. Also, an update on current technical parameters suitable for NSC transplantation and functional recovery in clinical studies are summarized.https://doi.org/10.1186/s13287-024-04089-1Genetic modificationNeural stem cellsCell therapyCentral nervous injury
spellingShingle Xiangwen Tang
Peng Deng
Lin Li
Yuqing He
Jinchao Wang
Dingjun Hao
Hao Yang
Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases
Stem Cell Research & Therapy
Genetic modification
Neural stem cells
Cell therapy
Central nervous injury
title Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases
title_full Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases
title_fullStr Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases
title_full_unstemmed Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases
title_short Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases
title_sort advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases
topic Genetic modification
Neural stem cells
Cell therapy
Central nervous injury
url https://doi.org/10.1186/s13287-024-04089-1
work_keys_str_mv AT xiangwentang advancesingeneticallymodifiedneuralstemcelltherapyforcentralnervoussysteminjuryandneurologicaldiseases
AT pengdeng advancesingeneticallymodifiedneuralstemcelltherapyforcentralnervoussysteminjuryandneurologicaldiseases
AT linli advancesingeneticallymodifiedneuralstemcelltherapyforcentralnervoussysteminjuryandneurologicaldiseases
AT yuqinghe advancesingeneticallymodifiedneuralstemcelltherapyforcentralnervoussysteminjuryandneurologicaldiseases
AT jinchaowang advancesingeneticallymodifiedneuralstemcelltherapyforcentralnervoussysteminjuryandneurologicaldiseases
AT dingjunhao advancesingeneticallymodifiedneuralstemcelltherapyforcentralnervoussysteminjuryandneurologicaldiseases
AT haoyang advancesingeneticallymodifiedneuralstemcelltherapyforcentralnervoussysteminjuryandneurologicaldiseases